eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform. Its mRNA-based TriMix technology boosts dendritic cells and mobilizes the immune system to attack cancer cells through inducing a directed cytotoxic T-cell response.